[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Magdi Yacoub Heart Foundation\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":90},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,44,70],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":20,"targetDuration":23,"studyType":24,"phases":4,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100490068","ahc-ballana-heart-study-100490068",false,"NCT05661318","AHC Ballana Heart Study","Aswan Heart Centre - Ballana Heart Study","AHC-BHS","Inclusion criteria:\n\n* Residents of Ballana from the 1,200 randomly selected households\n* Participants must have a valid National ID card\n* Written informed consent\n\nExclusion criteria:\n\n• Residents who are younger than 18 years",true,"ALL","18 Years",{"count":21,"type":22},5000,"ESTIMATED","30 Years","OBSERVATIONAL","This Study is designed to assess CVD incidence, prevalence, progression and related risk factors, including genetic background. It will provide an important base for all cardiovascular research activities in our centre and help in designing future studies and guide policy.",[27],"Genetic Predisposition to Disease",[29,30],"genetics","Cardiovascular risks","RECRUITING","2024-05-24",{"date":34,"type":35},"2024-05-29","ACTUAL",{"date":37,"type":35},"2018-01-01",{"date":39,"type":22},"2055-01-31",{"name":41,"class":42},"Magdi Yacoub Heart Foundation","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":17,"sex":18,"minAge":4,"maxAge":4,"enrollmentInfo":50,"targetDuration":52,"studyType":24,"phases":4,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":43},"100507246","egyptian-hypertrophic-cardiomyopathy-program-100507246","NCT05884892","Egyptian Hypertrophic Cardiomyopathy Program","Inclusion Criteria:\n\n* All patients diagnosed with hypertrophic cardiomyopathy (index patients) who are willing and consented to participate in the registry.\n* All family members of index patients who are willing and consented to participate in the registry.\n\nExclusion Criteria:\n\n* Refusal to consent to participate in the registry program.",{"count":51,"type":22},2000,"10 Years","Egyptian HCM program aims at defining incidence, severity, phenotype, genotype and determinants of the disease in Egypt, and providing state-of-the-art treatment strategies including medical, surgical and interventional procedures which are patient- and disease-specific.",[55],"Hypertrophic Cardiomyopathy",[57,58,55,59,60,61],"HCM","HOCM","Familial Hypertrophic Cardiomyopathy","Hypertrophic Cardiomyopathy with Genetic Marker","Hypertrophic Obstructive Cardiomyopathy","2023-05-23",{"date":64,"type":35},"2023-06-01",{"date":66,"type":35},"2014-01-01",{"date":68,"type":22},"2030-01-01",{"name":41,"class":42},{"id":71,"slug":72,"hasResults":11,"nctId":73,"briefTitle":74,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":77,"targetDuration":79,"studyType":24,"phases":4,"briefSummary":80,"conditions":81,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":43},"100490067","aswan-heart-centre---egyptian-healthy-volunteers-100490067","NCT05661305","Aswan Heart Centre - Egyptian Healthy Volunteers","AHC-EHVol","* Inclusion Criteria:\n\n  * Any adult Egyptian citizen subject that considers him\u002Fherself free of cardiovascular disease.\n* Exclusion Criteria:\n\n  * Individuals under 18 years of age\n  * Known cardiovascular disease\n  * Known collagen vascular disease\n  * Individuals with communication difficulties, or who do not wish to participate\n  * Pregnancy\n  * Contraindication to MRI\n  * Family history of sudden death\n  * Family history of a familial cardiomyopathy\n  * Family history of premature coronary artery disease (males \\\u003C40 years, females \\\u003C50 years).\n* Withdrawal Criteria:\n\n  * Withdrawal of consent.",{"count":78,"type":22},1000,"5 Years","To define the genotype of a healthy Egyptian cohort as a crucial step in determining the possible clinical implications of mutations detected in patients recruited in the registry.",[27],"2022-12-14",{"date":84,"type":35},"2022-12-22",{"date":86,"type":35},"2019-01-01",{"date":88,"type":22},"2030-01-31",{"name":41,"class":42},""]